CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 156 enrolled
Drug / intervention
Varenicline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01680887
NCT01680887Phase 2Completed
CompareCT.gov

A Phase II, Randomized, Double-Blind Trial of Varenicline for the Treatment of Cocaine Dependence

University of Pennsylvania·interventional·Posted Sep 7, 2012·Updated Aug 6, 2019

In Brief

A Phase 2 clinical trial evaluating Varenicline and Placebo for Cocaine Dependence. Completed, enrolled 156 participants across 1 site.

Detailed Summary

This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2012
Enrollment StartAug 1, 2012
Primary CompletionJan 1, 2018
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 13.8 years ago

Interventions

Vareniclinedrug

Placebodrug